ConcePTION
Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding
Details
- Period: 2019-04-30 – 2024-12-31
- Budget: 7,397,549 SEK
- Funder: Innovative Medicines Initiative
Safety evidence ecosystem
More than 5 million women get pregnant in the EU every year and a majority takes at least one medication during pregnancy. As few as 5% of available medications have been adequately monitored, tested and labelled with safety information for use in pregnant and breastfeeding women. The field, while inherently difficult to study, has suffered from a lack of systematically gathered insights that could lead to more effective data generation methodologies. Fragmentation and misinformation results in confusing and contradictory communication and perception of risks by both health professionals and women and their families.
ConcePTION is a public-private research project, funded by the Innovative Medicines Initiative, with the aim of increasing knowledge about drugs taken during pregnancy and lactation. Within the ConcePTION project, several studies are underway to investigate the impact of drugs both during pregnancy and during breastfeeding.
ConcePTION aims to establish a trusted ecosystem that can efficiently, systematically, and in an ethically responsible manner, generate and disseminate reliable evidence-based information regarding effects of medications used during pregnancy and breastfeeding to women and their healthcare providers. This will be achieved by generating, cataloguing, linking, collecting and analysing data from pharmacovigilance, modelling, routine healthcare, breastmilk samples through a large network.
ConcePTION in Sweden
In Sweden, in two demonstration studies, we will collect breast milk and blood samples from the mother and the baby for two drugs: metformin and prednisolone. In both cases, there is currently limited data, which is partly old from the 1970s, partly analyzed with outdated methods. The samples are transported to Uppsala Biobank for storage and analyzed with mass spectrometric methods at the Department of Pharmacy, Uppsala University.
Uppsala University is the sponsor of the studies, for more information, please contact Mats G. Hansson, senior professor. Are you currently breastfeeding and taking any of the medicines Metformin or Prednisolone? Consider participating in our study. To learn more about the study and sign up, visit the website for the Metformin study and the Prednisolone study (Swedish only). Or contact those responsible for the study via e-mail: metforminstudien@uu.se or prednisolonstudien@uu.se
Collaborators
ConcePTION unites 88 organisations from 22 countries
People in the project
Mats Hansson
Senior professor in biomedical ethics with expertise in clinical issues, genetics and biobanks. Research focus on drug safety during pregnancy and breastfeeding, and genetic screening.
Erica Sundell
Research assistant with a background as a nurse and public health scientist. Works with coordination, data collection and other study-specific tasks within various projects at the center.
Josepine Fernow
Science communicator, project manager, communications strategist and CRB coordinator. Develops strategy and plan for science communication and research impact at the center and in EU-funded research consortia.
Anna Holm Bodin
Science communicator and responsible for the Centre's web and social media. Responsible for communication in several EU-funded research consortia.
Fanny Klingvall
Science communicator working in EU-funded projects about gender equality and medication safety during pregnancy and breastfeeding.
